Natural Macromolecule-Based Nanocarriers for Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (31 May 2025) | Viewed by 818
Special Issue Editor
Interests: novel drug delivery systems; pharmaceutical nanotechnology, and multifunctional nanomaterials for controlled drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Natural macromolecules, including polysaccharides, proteins, nucleic acids, and lipids, are natural sources of biopolymeric materials which are not only biocompatible and biofunctional but they also have easily modified active groups in their structure that are highly effective in establishing fabricating nanocarriers for drug delivery. Natural macromolecules enable the construction of a wide variety of multifunctional drug delivery systems. They can be directly linked with drugs to form drug–polymer systems, prepared into nanoparticle encapsulated drugs and modified on the surface of various nanoparticles.
This Special Issue aims to provide a scientific platform for scientists to highlight recent advances in natural macromolecules-based drug delivery. In this Special Issue of Pharmaceutics, we invite authors to submit original research articles or reviews. Research areas may include, but are not limited to, the following topics: nanocarrier synthesis, mechanism research, theoretical developments, controlled release, targeted delivery, and molecule role in delivery.
I look forward to receiving your contributions.
Dr. Lipeng Qiu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- macromolecules
- polysaccharides
- proteins
- nucleic acids
- lipids
- nanocarrier
- drug delivery
- targeted delivery
- controlled release
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
